“The four anti-Cavid vaccines used in France are safe,” reaffirms the drug agency in its latest assessment of undesirable effects. To date, “more than 152 million doses” of anti-Cavid vaccines “have been administered” in France. “163,000 reports of suspected potential adverse effects have been recorded,” said Mehdi Benkebil, director of supervision of the ANSM (National Agency for Medicines).
“All of these cases have been the subject of analyzes. By way of comparison, annually we receive from around 40,000 cases for all drugs, “he said, highlighting the” colossal analysis work “that” reinforced monitoring “of anti-Cavid vaccines represents.
“Most often mild side effects”
According to this survey, the benefit/risk of COVIVS vaccines is very positive. But some side or unwanted effects have been highlighted, the most frequently mild. Rare cases of peripheral facial paralysis (partial loss of the functioning of part of the facial muscles), myocarditis/pericarditis (inflammation of the heart muscle), significant menstrual bleeding, and polymorphic erythema (eruption of skin spots) have been identified.
In its assessment of new effects hitherto not listed, the ANSM notes that “very rare cases” of “burn -type pain, mainly at the level of the feet and lower limbs (small fiber neuropathies), appeared” With the Pfizer vaccine, and other cases, also “very rare”, of chronic fatigue, with the Spikevax vaccine. They “are the subject of additional investigations”.
“No link with Charcot’s disease”
“Recently reported after vaccination with the vaccine” Pfizer, a case of Charcot’s disease, has been analyzed and “the data available to date” does not “allow you to retain a link” between the occurrence of the disease and the vaccine, writes the ANSM, after a “college exam with the regional centers of pharmacovigilance”.
This case is that of an Allier thirties, whose family and an association of victims have largely communicated on social networks and in the regional press around an supposed “official recognition” of a causal link between his illness and this vaccination. The regional pharmacovigilance center had sent a letter indicating that the reporting of the case was “registered, generating a file” with a view to “expertise work”.
Our file on anti-COVIVS vaccines
Already in 2022, the ANSM had examined about fifteen post-vaccination SLA reports, reports Joëlle Micallef, pharmacologist. “If these patients were well affected by SLA”, the vaccination cause had been dismissed in particular “because medically and pathophysiologically, Charcot’s disease cannot be triggered within such a short time”.
(Tagstotranslate) News (T) COVID 19 (T) Anti-COVIVE (T) Drug Vaccine (T)